Congenital stationary night blindness autosomal dominant 3: genes and variants
Explore variant evidence for Congenital stationary night blindness autosomal dominant 3 across 4 analyzed proteins (GNAT1, RHO, PDE6B, ABCA4). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 34 variants of uncertain significance and 32 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Congenital stationary night blindness autosomal dominant 3
GNAT1: Guanine nucleotide-binding protein G(t) subunit alpha-1
It transduces the light-activated rhodopsin signal in rod photoreceptors, activating phosphodiesterase and lowering cGMP to initiate visual responses. Pathogenic variants can cause congenital stationary night blindness or autosomal dominant rod-cone degeneration.
4 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in GNAT1 have source records linked to Congenital stationary night blindness autosomal dominant 3. Association strength is not clinical gene validity.
RHO: Rhodopsin
Photon absorption converts its retinal chromophore and triggers the G-protein cascade that initiates rod phototransduction. Pathogenic variants are a major cause of autosomal dominant retinitis pigmentosa and can also cause congenital stationary night blindness.
3 ClinVar pathogenic / likely pathogenic and 14 uncertain variants in RHO have source records linked to Congenital stationary night blindness autosomal dominant 3. Association strength is not clinical gene validity.
PDE6B: Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta
It hydrolyzes cyclic GMP after light activation in rod photoreceptors, causing cyclic-nucleotide-gated channels to close and initiating the electrical visual response. Biallelic loss-of-function variants cause retinitis pigmentosa, while certain variants can cause congenital stationary night blindness.
1 ClinVar pathogenic / likely pathogenic and 42 uncertain variants in PDE6B have source records linked to Congenital stationary night blindness autosomal dominant 3. Association strength is not clinical gene validity.
ABCA4: Retinal-specific phospholipid-transporting ATPase ABCA4
It flips retinal-derived lipid adducts across photoreceptor disc membranes so they can be cleared during the visual cycle. Biallelic loss-of-function variants cause Stargardt disease and can also produce cone-rod dystrophy or retinitis pigmentosa.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ABCA4 have source records linked to Congenital stationary night blindness autosomal dominant 3. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): GUCY2D and RLBP1.
ClinVar pathogenic and likely pathogenic variants linked to Congenital stationary night blindness autosomal dominant 3
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PDE6B D600N | 600 | PDEase | Pathogenic / likely pathogenic (★★) |
| GNAT1 K42E | 42 | G-alpha | Pathogenic / likely pathogenic (★) |
| RHO T94I | 94 | Transmembrane | Pathogenic / likely pathogenic (★) |
| RHO G121V | 121 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GNAT1 G38D | 38 | G-alpha | Pathogenic / likely pathogenic |
| ABCA4 K2076E | 2076 | ABC transporter 2 | Pathogenic / likely pathogenic |
| RHO A292E | 292 | Transmembrane | Pathogenic / likely pathogenic |
| GNAT1 D129G | 129 | G-alpha | Pathogenic / likely pathogenic |
| GNAT1 Q200E | 200 | G-alpha | Pathogenic / likely pathogenic |
Which prediction tools work for Congenital stationary night blindness autosomal dominant 3
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 99 out of 100
- PolyPhen-2: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 97 out of 100
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 92 out of 100
- MetaSVM: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 76 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Retinitis pigmentosa also has ClinVar records linked to RHO variants; they fall mostly in different places as the Congenital stationary night blindness autosomal dominant 3 variants (65 pathogenic / likely pathogenic).
- Fundus albipunctatus also has ClinVar records linked to RHO variants; they fall mostly in different places as the Congenital stationary night blindness autosomal dominant 3 variants (5 pathogenic / likely pathogenic).
- Retinal disorder also has ClinVar records linked to RHO variants; they fall mostly in different places as the Congenital stationary night blindness autosomal dominant 3 variants (3 pathogenic / likely pathogenic).
- Retinitis pigmentosa also has ClinVar records linked to PDE6B variants; they fall mostly in different places as the Congenital stationary night blindness autosomal dominant 3 variants (15 pathogenic / likely pathogenic).
- Severe early-childhood-onset retinal dystrophy also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Congenital stationary night blindness autosomal dominant 3 variants (148 pathogenic / likely pathogenic).
- ABCA4-related retinopathy also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Congenital stationary night blindness autosomal dominant 3 variants (60 pathogenic / likely pathogenic).
- Retinitis pigmentosa also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Congenital stationary night blindness autosomal dominant 3 variants (58 pathogenic / likely pathogenic).
- Stargardt disease also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Congenital stationary night blindness autosomal dominant 3 variants (41 pathogenic / likely pathogenic).
- Age related macular degeneration also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Congenital stationary night blindness autosomal dominant 3 variants (41 pathogenic / likely pathogenic).
Diseases related to Congenital stationary night blindness autosomal dominant 3
- Retinitis pigmentosa, also linked to ABCA4, GNAT1, PDE6B and RHO
- Retinal disorder, also linked to ABCA4 and RHO
- Autosomal recessive retinitis pigmentosa, also linked to ABCA4 and PDE6B
- Leber congenital amaurosis, also linked to ABCA4
- Severe early-childhood-onset retinal dystrophy, also linked to ABCA4
- Cone-rod dystrophy, also linked to ABCA4
- ABCA4-related retinopathy, also linked to ABCA4
- Stargardt disease, also linked to ABCA4
- Age related macular degeneration, also linked to ABCA4
- Optic atrophy, also linked to ABCA4
- Fundus albipunctatus, also linked to RHO
- Isolated macular dystrophy, also linked to ABCA4
Frequently asked questions
Which genes have records linked to Congenital stationary night blindness autosomal dominant 3?
This view contains 4 analyzed proteins: GNAT1, RHO, PDE6B, ABCA4. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 34 variants of uncertain significance and 32 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 88 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center